A young woman frames her face with one hand in a clean, minimalist composition devoted to aesthetic care. Her direct gaze is a reminder that behind the promise of beauty, every injection remains a medical procedure. Credit: Authentic Stock / StockSnap, CC0.
A 25-year-old woman died Monday, July 27, after collapsing in a beauty salon in Nice. Three people have been charged. Prosecutors say a lidocaine injection was supposed to precede an injection of botulinum toxin in the buttocks. The autopsy and toxicology tests are still pending: neither the product actually administered nor the cause of death has been established.
A Lidocaine Injection Before a Planned Procedure
The collapse occurred in the afternoon at an establishment in western Nice. Emergency responders were unable to revive the young woman, who died from cardiorespiratory arrest. The investigation has been handed to the local judicial police service under the authority of the Nice prosecutor’s office.
In a procedural update released July 30, prosecutors say a lidocaine injection, a local anesthetic, may have been administered. It was supposed to come before a botulinum toxin injection in the buttocks. That sequence does not prove the toxin was actually administered, much less that it caused the death.
Syringes, medications, and other injectable products were found on site, according to the prosecutor’s office. The business publicly advertised nail, hair, and eyelash services, but not injectable procedures. The nature, origin, and concentration of the seized substances have not been made public.
Three Charged, Responsibilities Still To Be Determined
The woman suspected of carrying out the injection and the salon manager have been placed in pretrial detention. The husband of the alleged injector has been placed under judicial supervision. All three were charged on July 30. They are presumed innocent, and each person’s exact role will have to be established by the investigation.
The investigation concerns, in particular, manslaughter, the illegal practice of medicine, and the administration of harmful substances. According to information released by prosecutors, the alleged practitioner had neither recognized training nor authorization to perform injections. The investigation also points to possible prior activity, which may have begun in 2022. These judicial findings do not prejudge either criminal responsibility or the medical cause of death.
The manager reportedly admitted to having performed injections herself before stopping. Her business reportedly had no administrative or tax registration, according to prosecutors. The third defendant said he did not know his wife’s activity was illegal. These accounts will have to be tested against interviews, seizures, and expert analyses.
Botulinum Toxin Is Not Lidocaine
Lidocaine and botulinum toxin are two distinct substances. The first is a local anesthetic used to temporarily reduce sensation in an area. The second is a neurotoxin used as a medication for certain medical indications and, under strict conditions, in aesthetic medicine.
The term Botox originally refers to a brand name, even though it is often used in everyday language to mean botulinum toxin. In the Nice case, that wording currently describes the planned procedure. It does not refer to a substance whose injection into the victim has been confirmed by testing.
The autopsy and toxicology tests will have to determine which products were administered, at what dose, and in what order. They will also have to determine whether the collapse resulted from a product or from the way it was administered. An individual reaction or another cause remains possible. Until those results are known, saying the death was caused by Botox would be premature.
Who Can Administer Botulinum Toxin in France?
Botulinum toxin is a prescription medication. The French National Agency for Medicines and Health Products Safety says its use for cosmetic purposes is reserved for authorized doctors. These include specialists in plastic, reconstructive, and cosmetic surgery, as well as dermatologists. The list also includes certain specialties involving the face, neck, jaw, and eyes.
The product used must have marketing authorization. That authorization confirms that its quality, effectiveness, and safety have been evaluated. Its purchase is also regulated, and online sales are prohibited. A service offered without recognized medical qualifications, at home or in an institute, therefore falls outside the authorized framework.
The term “fake injectors,” commonly used by some professionals, refers to people who offer aesthetic injections without the required qualifications. The trend is particularly promoted on social media. Low prices and images of immediate results can make a medical procedure look like a simple beauty treatment.
How Do You Recognize an Illegal Injection Offer?
The ANSM cites several warning signs: no verifiable medical qualifications, a nonmedical setting, or promises that there is no risk. Promotion on social media and especially attractive prices should also raise concerns. The agency also warns against buying botulinum toxin online. That practice is incompatible with its status as a prescription-only medication.
These criteria do not replace an examination of the product and the practitioner’s authorization. They do, however, underscore a simple rule: an aesthetic injection does not become a harmless treatment in a salon. Presenting it as a quick procedure does not change the risk. It involves a medication, an invasive gesture, and the ability to handle a complication.
Documented Risks, With No Established Link To the Nice Death
Botulinum toxin poisoning can cause botulism, a serious neurological disorder. It can lead to muscle weakness and problems with vision, swallowing, or breathing. The risk increases with an unauthorized product or an uncontrolled dose. It also increases when the injection is performed by someone who is not authorized.
In an initial alert updated in October 2025, the ANSM listed eight serious pharmacovigilance cases. They occurred between August and September 2024 after illegal injections. Three additional serious cases were later reported in France, with breathing difficulties that required intensive care.
These data establish a general health risk. However, they do not show any link between possible botulism and the death in Nice. No symptoms of that kind have been publicly attributed to the victim. The presence of botulinum toxin in her body remains to be confirmed.
What the Investigation Still Needs To Determine
As of July 30, the causes of death remain unknown. Investigators must identify the seized products, trace their origin, and verify their authorization. They will have to determine whether botulinum toxin was injected or whether only lidocaine was. The exact circumstances of the collapse also remain to be established.
The investigation will also have to establish the qualifications of the people involved, how the alleged activity was organized, and whether other clients may have been involved. A forensic medical report will be decisive in distinguishing the current theory from the actual mechanism of death. Until then, the case remains one of an unexplained death after an alleged injectable procedure, not one of a causation already proven.